vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and NPK International Inc. (NPKI). Click either name above to swap in a different company.
NPK International Inc. is the larger business by last-quarter revenue ($75.2M vs $62.1M, roughly 1.2× Cytek Biosciences, Inc.). On growth, NPK International Inc. posted the faster year-over-year revenue change (30.7% vs 8.1%). NPK International Inc. produced more free cash flow last quarter ($5.8M vs $-1.8M). Over the past eight quarters, NPK International Inc.'s revenue compounded faster (23.9% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CTKB vs NPKI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $75.2M |
| Net Profit | $-44.1M | — |
| Gross Margin | 52.9% | 37.7% |
| Operating Margin | -9.0% | 16.7% |
| Net Margin | -70.9% | — |
| Revenue YoY | 8.1% | 30.7% |
| Net Profit YoY | -557.1% | — |
| EPS (diluted) | — | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $75.2M | ||
| Q3 25 | $52.3M | $68.8M | ||
| Q2 25 | $45.6M | $68.2M | ||
| Q1 25 | $41.5M | $64.8M | ||
| Q4 24 | $57.5M | $57.5M | ||
| Q3 24 | $51.5M | $44.2M | ||
| Q2 24 | $46.6M | $66.8M | ||
| Q1 24 | $44.9M | $49.0M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $5.7M | ||
| Q2 25 | $-5.6M | $8.7M | ||
| Q1 25 | $-11.4M | $10.0M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $-174.3M | ||
| Q2 24 | $-10.4M | $8.0M | ||
| Q1 24 | $-6.2M | $7.3M |
| Q4 25 | 52.9% | 37.7% | ||
| Q3 25 | 52.7% | 31.9% | ||
| Q2 25 | 52.3% | 36.9% | ||
| Q1 25 | 48.6% | 39.0% | ||
| Q4 24 | 58.5% | 39.2% | ||
| Q3 24 | 56.3% | 27.5% | ||
| Q2 24 | 54.6% | 37.2% | ||
| Q1 24 | 51.3% | 36.0% |
| Q4 25 | -9.0% | 16.7% | ||
| Q3 25 | -17.6% | 13.2% | ||
| Q2 25 | -23.3% | 17.0% | ||
| Q1 25 | -36.1% | 20.9% | ||
| Q4 24 | 5.2% | 20.2% | ||
| Q3 24 | -8.2% | 2.8% | ||
| Q2 24 | -18.3% | 18.7% | ||
| Q1 24 | -23.9% | 14.2% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 8.2% | ||
| Q2 25 | -12.2% | 12.7% | ||
| Q1 25 | -27.5% | 15.4% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | -394.3% | ||
| Q2 24 | -22.4% | 12.0% | ||
| Q1 24 | -13.8% | 14.9% |
| Q4 25 | — | $0.17 | ||
| Q3 25 | — | $0.07 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $0.11 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $-1.99 | ||
| Q2 24 | — | $0.09 | ||
| Q1 24 | — | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $5.1M |
| Total DebtLower is stronger | — | $16.9M |
| Stockholders' EquityBook value | $341.7M | $351.2M |
| Total Assets | $461.5M | $441.8M |
| Debt / EquityLower = less leverage | — | 0.05× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $5.1M | ||
| Q3 25 | $93.3M | $35.6M | ||
| Q2 25 | $75.5M | $26.0M | ||
| Q1 25 | $95.3M | $20.8M | ||
| Q4 24 | $98.7M | $17.8M | ||
| Q3 24 | $162.3M | $42.9M | ||
| Q2 24 | $177.9M | $35.1M | ||
| Q1 24 | $168.8M | $37.7M |
| Q4 25 | — | $16.9M | ||
| Q3 25 | — | $9.5M | ||
| Q2 25 | — | $9.3M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $7.7M | ||
| Q3 24 | — | $14.0M | ||
| Q2 24 | — | $58.0M | ||
| Q1 24 | — | $77.4M |
| Q4 25 | $341.7M | $351.2M | ||
| Q3 25 | $378.6M | $333.9M | ||
| Q2 25 | $377.6M | $328.8M | ||
| Q1 25 | $379.6M | $326.9M | ||
| Q4 24 | $395.7M | $326.5M | ||
| Q3 24 | $385.5M | $316.5M | ||
| Q2 24 | $389.1M | $426.6M | ||
| Q1 24 | $392.6M | $421.6M |
| Q4 25 | $461.5M | $441.8M | ||
| Q3 25 | $494.9M | $404.5M | ||
| Q2 25 | $493.3M | $393.7M | ||
| Q1 25 | $482.6M | $390.0M | ||
| Q4 24 | $499.5M | $393.7M | ||
| Q3 24 | $491.2M | $389.6M | ||
| Q2 24 | $483.7M | $624.8M | ||
| Q1 24 | $492.1M | $640.8M |
| Q4 25 | — | 0.05× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $18.0M |
| Free Cash FlowOCF − Capex | $-1.8M | $5.8M |
| FCF MarginFCF / Revenue | -2.9% | 7.6% |
| Capex IntensityCapex / Revenue | 1.6% | 16.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $26.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $18.0M | ||
| Q3 25 | $-3.9M | $24.7M | ||
| Q2 25 | $108.0K | $21.4M | ||
| Q1 25 | $-125.0K | $8.8M | ||
| Q4 24 | $2.0M | $-4.1M | ||
| Q3 24 | $13.2M | $2.8M | ||
| Q2 24 | $6.2M | $27.6M | ||
| Q1 24 | $4.0M | $11.9M |
| Q4 25 | $-1.8M | $5.8M | ||
| Q3 25 | $-4.6M | $12.0M | ||
| Q2 25 | $-1.5M | $9.7M | ||
| Q1 25 | $-974.0K | $-1.2M | ||
| Q4 24 | $1.1M | $-17.7M | ||
| Q3 24 | $12.2M | $-6.7M | ||
| Q2 24 | $5.2M | $21.0M | ||
| Q1 24 | $3.4M | $-1.9M |
| Q4 25 | -2.9% | 7.6% | ||
| Q3 25 | -8.7% | 17.4% | ||
| Q2 25 | -3.2% | 14.3% | ||
| Q1 25 | -2.3% | -1.8% | ||
| Q4 24 | 1.9% | -30.8% | ||
| Q3 24 | 23.7% | -15.2% | ||
| Q2 24 | 11.0% | 31.4% | ||
| Q1 24 | 7.6% | -3.9% |
| Q4 25 | 1.6% | 16.3% | ||
| Q3 25 | 1.3% | 18.5% | ||
| Q2 25 | 3.5% | 17.1% | ||
| Q1 25 | 2.0% | 15.5% | ||
| Q4 24 | 1.6% | 23.6% | ||
| Q3 24 | 2.0% | 21.4% | ||
| Q2 24 | 2.3% | 9.9% | ||
| Q1 24 | 1.3% | 28.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.37× | ||
| Q2 25 | — | 2.47× | ||
| Q1 25 | — | 0.88× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | 3.43× | ||
| Q1 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
NPKI
| Rental Revenue | $34.8M | 46% |
| Products | $25.5M | 34% |
| Services | $14.9M | 20% |
